ProKidney Corp. (PROK) is a biotechnology company listed on US.
Latest reported PROK revenue for 2026-06-30 was $376.0K. Net income was -$48.5M. Revenue was up 66.4% from 2026-03-31 to 2026-06-30. PROK currently screens at market cap $543.7M.
Use this PROK page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PROK quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PROK SEC filings page. Lician reads the product cache first so this HTML stays unique to ProKidney Corp. even when a live quote feed is slow.
Latest cached year on this hub. Full PROK income, balance, and cash tables.